The Collaborative Ocular Tuberculosis Study (COTS)-1: A Multinational Review of 165 Patients with Tubercular Anterior Uveitis

Agrawal R., Betzler B., Testi I., Mahajan S., Agarwal A., Gunasekeran D. V., ...Daha Fazla

OCULAR IMMUNOLOGY AND INFLAMMATION, cilt.28, ss.17-26, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 28
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1080/09273948.2020.1761400
  • Dergi Adı: OCULAR IMMUNOLOGY AND INFLAMMATION
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, CINAHL, EMBASE, MEDLINE, Veterinary Science Database
  • Sayfa Sayıları: ss.17-26
  • Anahtar Kelimeler: Anti-tubercular therapy, tubercular anterior uveitis, ocular tuberculosis, uveitis, collaborative ocular tuberculosis study (COTS), THERAPY, POPULATION, DIAGNOSIS
  • İstanbul Üniversitesi Adresli: Evet

Özet

Purpose The Collaborative Ocular Tuberculosis Study (COTS) Group sought to address the diagnostic uncertainty through retrospective cohort analysis of treatment regimens and therapeutic outcomes for patients with tubercular Anterior Uveitis (TAU) across international centers. Methods Multicentre retrospective analysis of patients diagnosed with TAU between January 2004 to December 2014 that had a minimum follow-up of 1 year. Results One hundred and sixty-five patients were included. One hundred and seven subjects received antitubercular therapy (ATT) (n = 107/165; 64.9%) with all the patients receiving topical steroid therapy. Treatment failure was noted in 17 patients (n = 17/165; 10.3%), more frequently described in patients that received ATT (n = 13/107, 12.2%), than those that did not receive ATT (n = 4/58, 6.9%). Conclusion In this retrospective study, addition of ATT did not have any statistically significant impact on outcome in patients with TAU.